Endoscopic ultrasound-guided liver biopsy in liver transplant recipients: A preliminary experience  

作　　者：Wei Rao Yue-Ping Jiang Jin-Zhen Cai Man Xie 

机构地区：[1]Division of Hepatology,Liver Disease Center,the Affiliated Hospital of Qingdao University,Qingdao 266000,China [2]Department of Organ Transplantation,the Affiliated Hospital of Qingdao University,Qingdao 266000,China [3]Department of Gastroenterology,the Affiliated Hospital of Qingdao University,Qingdao 266000,China

出　　处：《Hepatobiliary & Pancreatic Diseases International》2025年第1期108-110,共3页国际肝胆胰疾病杂志(英文版)

基　　金：supported by a grant from 2021 Shandong Provincial Social Science Popularization and Application Research Project (2021-SKZC-18)。

摘　　要：To the Editor:With the popularity of liver transplantation(LT)and the inspiration for long-time survival,issues related to evaluating the liver allograft have increased in recent years[1-3].Although there has been renewed interest in non-invasive methods to evaluate diffuse liver disease,liver biopsy is still the golden standard in clinical practice,particularly for liver transplant recipients(LTRs).The liver biopsy has always been performed in LTRs as a part of standard procedure in cases whose liver function was normal,named as protocol liver biopsy,or to identify histological abnormalities for abnormal liver function and provide guidance for the adjustment of immunosuppressive regimen[4,5].Percutaneous liver biopsy(PLB)has been frequently conducted in LTRs;however,the clinical implementation of protocol liver biopsy by PLB in LTRs is challenging due to their suboptimal compliance,particularly in China[6].Besides,the PLB procedure has been associated with discomfort and potentially life-threatening complications in the general population,as reported in the literature[7,8].

关 键 词：BIOPSY PRELIMINARY COMFORT 

分 类 号：R57[医药卫生—消化系统]